John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$153M |
| 2 |
LNKD
LinkedIn Corporation
LNKD
|
+$130M |
| 3 |
Cummins
CMI
|
+$121M |
| 4 |
Lowe's Companies
LOW
|
+$104M |
| 5 |
American Express
AXP
|
+$101M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$445M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$200M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$165M |
| 4 |
Gilead Sciences
GILD
|
+$158M |
| 5 |
Microsoft
MSFT
|
+$153M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.25% |
| 2 | Healthcare | 12.59% |
| 3 | Industrials | 11.99% |
| 4 | Financials | 10.09% |
| 5 | Consumer Discretionary | 9.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
B
226
Barrick Mining
B
$78.3B
| $22.5M | 0.11% |
3,051,790
+3,010,253
| +7,247% | +$22.4M |
|
227
East-West Bancorp
EWBC
$17.8B
| $22.3M | 0.11% |
535,901
-320,964
| -37% | -$13.2M |
|
228
AT&T
T
$173B
| $22.2M | 0.11% |
854,564
-5,849,932
| -87% | -$148M |
|
229
Allison Transmission
ALSN
$11B
| $22.2M | 0.11% |
857,810
-155,643
| -15% | -$4.25M |
|
230
American Electric Power
AEP
$65.8B
| $22.2M | 0.11% |
380,740
+348,766
| +1,091% | +$19.8M |
|
231
Intel
INTC
$476B
| $22.1M | 0.11% |
641,194
-2,473,301
| -79% | -$83.6M |
|
|
NUAN
232
DELISTED
Nuance Communications, Inc.
NUAN
| $22M | 0.11% |
+1,274,671
| New | +$20.7M |
|
|
233
Gilead Sciences
GILD
$181B
| $21.6M | 0.1% |
213,231
-1,519,260
| -88% | -$158M |
|
234
Canadian Solar
CSIQ
$988M
| $21.5M | 0.1% |
+742,859
| New | +$17.1M |
|
235
Cadence Design Systems
CDNS
$87.9B
| $21.5M | 0.1% |
1,031,642
+812,125
| +370% | +$17.6M |
|
236
Kroger
KR
$35.5B
| $21.4M | 0.1% |
510,758
-834,290
| -62% | -$32.3M |
|
237
Ulta Beauty
ULTA
$22.4B
| $21.3M | 0.1% |
115,204
+4,113
| +4% | +$711K |
|
|
CIT
238
DELISTED
CIT Group Inc.
CIT
| $21.3M | 0.1% |
+535,715
| New | +$22.5M |
|
239
Trane Technologies
TT
$99.8B
| $21M | 0.1% |
379,824
-369,114
| -49% | -$20.8M |
|
240
American Tower
AMT
$81.9B
| $21M | 0.1% |
216,173
-595,904
| -73% | -$58.1M |
|
241
Delta Air Lines
DAL
$54.2B
| $20.7M | 0.1% |
407,633
-1,037,858
| -72% | -$51.3M |
|
242
Bloomin' Brands
BLMN
$996M
| $20.5M | 0.1% |
1,212,613
+633,314
| +109% | +$11M |
|
243
Coca-Cola Europacific Partners
CCEP
$47.7B
| $20.2M | 0.1% |
409,608
+106,917
| +35% | +$5.38M |
|
244
Micron Technology
MU
$1.09T
| $20M | 0.1% |
1,408,961
+865,069
| +159% | +$13.8M |
|
245
Viatris
VTRS
$18.7B
| $19.9M | 0.1% |
+368,804
| New | +$17.7M |
|
246
Myriad Genetics
MYGN
$306M
| $19.9M | 0.1% |
461,993
+190,733
| +70% | +$8.06M |
|
247
FedEx
FDX
$76.9B
| $19.9M | 0.1% |
133,495
-260,579
| -66% | -$40.3M |
|
248
Ambev
ABEV
$44.4B
| $19.7M | 0.09% |
4,426,087
+3,537,602
| +398% | +$17.3M |
|
|
SOHU
249
Sohu.com
SOHU
$372M
| $19.6M | 0.09% |
343,416
-52,029
| -13% | -$2.63M |
|
250
PUT
Verizon
VZ
$205B
| $19.6M | 0.09% |
423,000
+346,000
| +449% | +$15.7M |
|
Similar funds
John Overdeck's Q4 2015 Portfolio in Review
As of Q4 2015, John Overdeck held 3,233 positions worth $20.9B, up 6.8% from $19.5B the previous quarter. Its ten largest holdings account for 8% of the portfolio.
John Overdeck deployed $631M of net new capital in Q4 2015, opening 1,109 new positions and adding to 884 existing holdings. Its largest new stake was American Express: 1,381,273 shares worth $96.1M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Gilead Sciences, an estimated $158M trimmed.
- John Overdeck's largest Q4 2015 buy was American Express: 1,381,273 shares worth $96.1M.
- John Overdeck added most to Allergan plc in Q4 2015, an estimated $153M increase.
- John Overdeck's biggest Q4 2015 reduction was Gilead Sciences, cutting an estimated $158M.
- John Overdeck fully exited State Street SPDR S&P 500 ETF Trust in Q4 2015, selling an estimated $445M.
- John Overdeck's ten largest holdings make up 8% of its $20.9B portfolio in Q4 2015.
- John Overdeck opened 1,109 new positions and closed 598 in Q4 2015.
- John Overdeck's portfolio value rose 6.8% quarter-over-quarter to $20.9B.
Based on Two Sigma Investments's 13F filing for Q4 2015, filed 16 Feb 2016.